TickerFactsScreenerDevelopers

Fulcrum Therapeutics, Inc. (FULC) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2018: -$22.56M2019: -$39.48M2020: -$53.66M2021: -$78.48M2022: -$97.05M2023: -$90.97M2024: -$2.22M2025: -$60.06M-$60.06M
2018Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$60.06M-2608.1%
2024-$2.22M+97.6%
2023-$90.97M+6.3%
2022-$97.05M-23.7%
2021-$78.48M-46.3%
2020-$53.66M-35.9%
2019-$39.48M-75.0%
2018-$22.56M—